Webinar

UPCOMING! Exploring the application of deterministically programmed hiPSCs to advance early-stage drug discovery 

Explore real-world applications of bit.bio’s ioCells across early drug discovery, from target ID to toxicology.
UPCOMING! Exploring the application of deterministically programmed hiPSCs to advance early-stage drug discovery 

Thomas Moreau, PhD

VP Cell Programming Research

bit.bio

UPCOMING! Exploring the application of deterministically programmed hiPSCs to advance early-stage drug discovery 

Ann Byrne, MSc

Regional Sales Manager, APAC

bit.bio

UPCOMING! Exploring the application of deterministically programmed hiPSCs to advance early-stage drug discovery 

Gianmarco Mastrogiovanni, PhD

Principle Scientist - Cell Type Development 

bit.bio

UPCOMING! Exploring the application of deterministically programmed hiPSCs to advance early-stage drug discovery 
Explore real-world applications of bit.bio’s ioCells across early drug discovery, from target ID to toxicology.
UPCOMING! Exploring the application of deterministically programmed hiPSCs to advance early-stage drug discovery 

Thomas Moreau, PhD

VP Cell Programming Research

bit.bio

UPCOMING! Exploring the application of deterministically programmed hiPSCs to advance early-stage drug discovery 

Ann Byrne, MSc

Regional Sales Manager, APAC

bit.bio

UPCOMING! Exploring the application of deterministically programmed hiPSCs to advance early-stage drug discovery 

Gianmarco Mastrogiovanni, PhD

Principle Scientist - Cell Type Development 

bit.bio

In drug discovery, researchers need reliable, ready-to-use human cell models that deliver reproducible results at every stage of the workflow. Hear experts as they present data on the application of bit.bio’s deterministically programmed human iPSC-derived ioCells across key drug discovery stages. Through case studies and real-world applications, you will learn how these cells and the associated protocols support workflows in target identification, assay development, disease modelling, and toxicology.

Key learning points

  • Discover quick and easy generation of gene knockouts and CRISPR screens for target ID and validation in human iPSC-derived neurons and microglia using CRISPR-Ready ioCells
  • Learn about assay development in neuroinflammation and demyelinating diseases using neuronal and glial co-cultures
  • Explore rapidly maturing, consistent human iPSC-derived disease models for neurodegenerative disorders such as Huntington’s and Alzheimer’s disease
  • See data for predicting drug-induced liver injury in toxicology studies with new human iPSC-derived liver models

Date

26th Aug 2025

Time

8am PDT | 11am EDT | 4pm BST | 5pm CEST

Related pages

News Read our latest updates and press coverage
Our platform Discover the cell coding platform behind our cells
Join us Explore the latest roles at bit.bio